Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | DAO | P14920 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.30 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.30 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.30 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.30 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL427427 | 0.80 | LPO (0.32) | MEN1KMT2A | |
| SCHEMBL2490715 | 0.80 | DAO (0.40) | MEN1KMT2ADAOALDH1A1MAPT | |
| SCHEMBL6037466 | 0.75 | PARP1 (0.38) | KMT2ADAO | |
| SCHEMBL12231817 | 0.75 | RAB9A (0.34) | MEN1KMT2AALDH1A1 | |
| SCHEMBL28313542 | 0.72 | KMT2A (0.35) | MEN1KMT2ADAOALDH1A1MAPT | |
| SCHEMBL16575964 | 0.72 | LMNA (0.37) | MEN1KMT2ADAOALDH1A1MAPT | |
| SCHEMBL24316295 | 0.64 | MET (0.40) | MEN1KMT2ADAOALDH1A1HPGD | |
| SCHEMBL7012203 | 0.62 | PLA2G7 (0.44) | DAO | |
| SCHEMBL27905994 | 0.61 | NPC1 (0.36) | MEN1KMT2AUSP2KEAP1NFE2L2 | |
| SCHEMBL18878179 | 0.61 | TSHR (0.39) | KMT2AKAT2BBRD9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104105489-A | Application of nematode micromolecules | CALIFORNIA INSTTITUTE OF TECHNOLOGY | 2014-10-15 | — | — | CN | disclosed |
| CN-104059911-A | Single-stranded Nucleic Acid Molecule Having Nitrogen-containing Alicyclic Skeleton | BONAC CORP | 2014-09-24 | — | — | CN | disclosed |
| CN-104004018-A | Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton | BONAC CORP | 2014-08-27 | — | — | CN | disclosed |
| CN-103052711-A | Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton | BONAC CORP | 2013-04-17 | — | — | CN | disclosed |
| CN-102918156-A | Single-stranded nucleic acid molecules for controlling gene expression | BONAC CORP | 2013-02-06 | — | — | CN | disclosed |
| CN-102625696-A | Improved lipid formulations | ALNYLAM PHARMACEUTICALS INC | 2012-08-01 | — | — | CN | disclosed |
| CN-102361650-A | Novel lipids and compositions for delivery of therapeutic agents | ALNYLAM PHARMACEUTICALS INC | 2012-02-22 | — | — | CN | disclosed |
| CN-102281899-A | Novel lipids and compositions for delivery of therapeutic agents | — | 2011-12-14 | — | — | CN | disclosed |
| CN-101980603-A | Use of LINGO-1 and TrkB antagonists | BIOGEN IDEC INC | 2011-02-23 | — | — | CN | disclosed |
| CN-1345329-A | Tumor mecrosis factor receptors 6 alpha and beta | HUMAN GENOME SCIENCES INC (US) | 2002-04-17 | — | — | CN | disclosed |